MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
285.83%
Quick Ratio
285.83%
Cash Ratio
44.16%
Debt to Asset Ratio
81.44%
Unit: Thousand (K) dollars
Assets Breakdown
    • Total current assets
    • Property and equipment, net
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Royalty monetization liabilities
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
36,487
15,229
34,466
58,802
Marketable securities
69,030
135,262
195,604
215,403
Accounts receivable
106,754
10,038
26,379
25,347
Prepaid expenses
11,904
11,543
11,927
12,943
Restricted cash
225
-
-
-
Other current assets
11,757
14,444
12,905
19,472
Total current assets
236,157
186,516
281,281
331,967
Marketable securities
-
-
10,785
27,838
Accounts receivable
435
420
2,312
2,765
Total property and equipment
192,380
192,879
192,047
191,054
Accumulated depreciation and amortization
93,928
91,005
87,192
83,539
Property and equipment, net
98,452
101,874
104,855
107,515
Operating lease right-of-use assets
43,867
45,541
47,156
48,820
Restricted cash
1,805
2,030
2,030
2,030
Other assets
5,902
5,513
4,613
4,268
Total assets
386,618
341,894
453,032
525,203
Accounts payable
15,546
21,207
21,358
22,266
Accrued expenses and other current liabilities
23,073
21,892
38,390
38,316
Deferred revenue
9,882
5,919
10,452
13,195
Operating lease liabilities
7,355
7,867
8,286
9,073
Royalty monetization liabilities
26,765
14,225
39,609
41,718
Total current liabilities
82,621
71,110
118,095
124,568
Deferred revenue
15,404
22,776
18,943
21,186
Operating lease liabilities
61,596
63,199
65,215
67,433
Royalty monetization liabilities
154,746
163,105
147,408
149,916
Other liabilities
486
622
638
648
Total liabilities
314,853
320,812
350,299
363,751
Common stock 0.0001 par value 100,000 shares authorized at june 30, 2026 and december 31, 2025 54,164 and 50,892 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
5
5
5
5
Additional paid-in capital
1,266,004
1,238,025
1,229,442
1,220,977
Accumulated other comprehensive loss
-875
-870
-687
-652
Accumulated deficit
-1,193,369
-1,216,078
-1,126,027
-1,058,878
Total stockholders equity
71,765
21,082
102,733
161,452
Total liabilities and stockholders equity
386,618
341,894
453,032
525,203
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable$106,754K (428.51%↑ Y/Y)Marketable securities$69,030K (-71.68%↓ Y/Y)Cash and cashequivalents$36,487K (-54.14%↓ Y/Y)Prepaid expenses$11,904K (10.47%↑ Y/Y)Other current assets$11,757K (-39.64%↓ Y/Y)Restricted cash$225K (-88.92%↓ Y/Y)Total property andequipment$192,380K (0.68%↑ Y/Y)Total current assets$236,157K (-36.81%↓ Y/Y)Property and equipment,net$98,452K (-11.32%↓ Y/Y)Operating leaseright-of-use assets$43,867K (-13.08%↓ Y/Y)Other assets$5,902K (214.10%↑ Y/Y)Restricted cash$1,805K (-11.08%↓ Y/Y)Accounts receivable$435K (-72.54%↓ Y/Y)Accumulated depreciationand amortization$93,928K (17.33%↑ Y/Y)Total assets$386,618K (-33.46%↓ Y/Y)Total liabilities andstockholders equity$386,618K (-33.46%↓ Y/Y)Total liabilities$314,853K (-14.29%↓ Y/Y)Total stockholdersequity$71,765K (-66.41%↓ Y/Y)Accumulated deficit-$1,193,369K (-19.70%↓ Y/Y)Accumulated othercomprehensive loss-$875K (-16.67%↓ Y/Y)Royalty monetizationliabilities$154,746K (0.69%↑ Y/Y)Total currentliabilities$82,621K (-30.88%↓ Y/Y)Operating leaseliabilities$61,596K (-11.56%↓ Y/Y)Deferred revenue$15,404K (-35.29%↓ Y/Y)Other liabilities$486K (-26.81%↓ Y/Y)Additional paid-in capital$1,266,004K (4.51%↑ Y/Y)Common stock 0.0001 parvalue 100,000 shares...$5K (0.00%↑ Y/Y)Royalty monetizationliabilities$26,765K (-33.59%↓ Y/Y)Accrued expenses andother current...$23,073K (-35.11%↓ Y/Y)Accounts payable$15,546K (-28.21%↓ Y/Y)Deferred revenue$9,882K (-29.30%↓ Y/Y)Operating leaseliabilities$7,355K (-8.62%↓ Y/Y)

REGENXBIO Inc. (RGNX)

REGENXBIO Inc. (RGNX)